(Reuters) - India’s Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts’ estimates.
Net profit came in at 5.29 billion rupees ($78.49 million) in the quarter ended March 31, compared with 5.32 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said.
Analysts on average had expected a profit of 5.98 billion rupees, according to Thomson Reuters data.
Net sales rose over 11 percent to 39.89 billion rupees.
($1 = 67.3950 Indian rupees)
Reporting By Arnab Paul and Aby Jose Koilparambil in Bengaluru; Editing by Edmund Blair